Amarantus BioScience Holdings, Inc.
AMBS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -99.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -4,755.6% | – | -564.5% | 92.7% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -4,995.2% | – | -840.7% | 91.9% |
| EPS Diluted | -0.008 | -0.022 | -0.002 | 0.068 |
| % Growth | 62.6% | -1,188.2% | -102.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |